What is Egrifta?

Egrifta is the brand name for tesamorelin, a drug used to treat people infected with human immunodeficiency virus (HIV) who have developed a condition called lipodystrophy. That condition causes fat to accumulate in their abdomens. Egrifta is usually injected into the abdomen once a day. It can decrease the amount of fat in that area, though it does not cause overall weight loss.

Continue Learning about Endocrine-Metabolic Agent

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.